Evidence map›Paper›PMID 18025301›Full record

ArticleThe Journal of cell biology2007

The ATR-mediated S phase checkpoint prevents rereplication in mammalian cells when licensing control is disrupted.

Enbo Liu, Alan Yueh-Luen Lee, Takuya Chiba, Erin Olson, Peiqing Sun, Xiaohua Wu

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Molecular genetic response to varied wavelengths of light in Xiphophorus maculatus skin.Comparative biochemistry and physiology. Toxicology & pharmacology : CBP · 2015
    Article
  17. DNA replication origin activation in space and time.Nature reviews. Molecular cell biology · 2015
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Enbo LiuDepartment of Molecular Experimental Medicine and 2Department of Molecular Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
Alan Yueh-Luen Lee
Takuya Chiba
Erin Olson
Peiqing Sun
Xiaohua Wu
Scripps Research Institute · US

Funding

Role of the Mre11/Rad50/Nbs1 complex in DNA damage response pathwaysR01CA102361 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI WU, XIAOHUA · 2003 to 2012
$4.1M
NCI NIH HHS CA102361NCI NIH HHS R01 CA102361NIA NIH HHS AG-NS-0251-04
6 · The paper itself

Abstract

DNA replication in eukaryotic cells is tightly controlled by a licensing mechanism, ensuring that each origin fires once and only once per cell cycle. We demonstrate that the ataxia telangiectasia and Rad3 related (ATR)-mediated S phase checkpoint acts as a surveillance mechanism to prevent rereplication. Thus, disruption of licensing control will not induce significant rereplication in mammalian cells when the ATR checkpoint is intact. We also demonstrate that single-stranded DNA (ssDNA) is the initial signal that activates the checkpoint when licensing control is compromised in mammalian cells. We demonstrate that uncontrolled DNA unwinding by minichromosome maintenance proteins upon Cdt1 overexpression is an important mechanism that leads to ssDNA accumulation and checkpoint activation. Furthermore, we show that replication protein A 2 and retinoblastoma protein are both downstream targets for ATR that are important for the inhibition of DNA rereplication. We reveal the molecular mechanisms by which the ATR-mediated S phase checkpoint pathway prevents DNA rereplication and thus significantly improve our understanding of how rereplication is prevented in mammalian cells.

Indexed as

DNA ReplicationS PhaseAdenoviridaeAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsCell LineCell Line, TumorCheckpoint Kinase 1Checkpoint Kinase 2Chromosomal Proteins, Non-HistoneDNA-Binding ProteinsDNA DamageDNA, Single-StrandedEnzyme ActivationHeLa CellsHumansAtaxia Telangiectasia Mutated ProteinsATM protein, humanATR protein, humanCDT1 protein, humanCell Cycle ProteinsCheckpoint Kinase 1Checkpoint Kinase 2CHEK2 protein, humanChromosomal Proteins, Non-HistoneDNA-Binding ProteinsDNA, Single-StrandedNuclear ProteinsProtein KinasesProtein Serine-Threonine KinasesReplication Protein ARetinoblastoma ProteinRNA, Small InterferingTumor Suppressor Proteins

Identifiers

PMID18025301
PMCPMC2080923
OpenAlexW1976845879

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.